Specifically, the scores for CD8 + T cells, Th cells, B cells, and CYT were significantly lower in the high-risk subgroup, indicating that anti-tumor capacity in this subgroup was weaker than that in the low-risk subgroup. The gene discussed is CD8A; the disease is neoplasm.